Xponance Inc. Sells 52 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Xponance Inc. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 35,330 shares of the company’s stock after selling 52 shares during the quarter. Xponance Inc.’s holdings in HCA Healthcare were worth $11,351,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Royal Bank of Canada increased its stake in shares of HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares in the last quarter. Capital World Investors increased its holdings in HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares in the last quarter. Sanders Capital LLC increased its holdings in shares of HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $131,527,000. Finally, TD Asset Management Inc lifted its holdings in shares of HCA Healthcare by 230.5% in the 4th quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after acquiring an additional 385,854 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on HCA. Oppenheimer increased their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Barclays boosted their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. JPMorgan Chase & Co. lifted their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a report on Thursday, May 30th. Finally, Baird R W raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

Insider Activity

In related news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $405.71 on Tuesday. The company has a market cap of $106.26 billion, a PE ratio of 20.22, a P/E/G ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $409.42. The company’s fifty day simple moving average is $372.34 and its 200-day simple moving average is $341.21. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.29 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.